Consumer group petitions FDA to ban obesity drug Meridia

12/3/2009 | Google

Consumer group Public Citizen urged the FDA to pull Abbott Laboratories' Meridia from the market in light of a study linking the obesity drug to a heightened risk of heart attack, stroke and death. Abbott clarified that Meridia is not promoted for patients with a history of cardiovascular disease and "is not recommended or approved for use in more than 90% of the patients" in the study cited by Public Citizen.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA